LKFT · Lakefront Biotherapeutics NV · Webcasts, Transcripts & Audio
$32.28
-0.05 (-0.15%)
At close · Oct 30
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$2.13B
Shares
65.90M
Volume · Oct 30
164.06K
Avg daily vol (3M)
283.93K
Lakefront Biotherapeutics NV Webcasts
Earnings calls, investor updates, investor days and conferences for Lakefront Biotherapeutics NV (LKFT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-11
Lakefront Biotherapeutics NV (LKFT) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Lakefront Biotherapeutics NV (LKFT) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-10
Lakefront Biotherapeutics NV (LKFT) Q2 2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Lakefront Biotherapeutics NV (LKFT) Q1 2026 Earnings Call Transcript
Confident tone
Gimgertemik (GLPG) BCMA CD3 T-cell engager clinical profile
ORO transaction and Gilead relationship
Business development and capital allocation
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-31
Lakefront Biotherapeutics NV (LKFT) March 31, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-31
Lakefront Biotherapeutics NV (LKFT) March 31, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-24
Lakefront Biotherapeutics NV (LKFT) Q4 2025 Earnings Call Transcript
Positive tone
Cash position and capital allocation
Gilead collaboration and OLCA
Strategic transformation and pivot away from cell therapy
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q3 2025 Earnings Call Transcript
Cautious tone
Gilead Collaboration
Jyseleca Royalties
Cell Therapy Wind-Down
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
Lakefront Biotherapeutics NV (LKFT) Q1 2025 Earnings Call Transcript
Positive tone
SpinCo separation and leadership transition
Cell therapy pipeline and clinical progress
Partnerships and external collaborators
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-08
Lakefront Biotherapeutics NV (LKFT) Q4 2024 Earnings Call Transcript
Confident tone
Cell therapy pipeline and CD19 CAR-T (GLPG5101 / ATALANTA)
Planned separation into Galapagos and SpinCo
Decentralized manufacturing platform (Cocoon / DMU)
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q3 2024 Earnings Call Transcript
Positive tone
CAR-T cell therapy pipeline and decentralized manufacturing
Clinical trial timelines and data readouts
Pipeline expansion and discovery portfolio
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q2 2024 Earnings Call Transcript
Positive tone
Cell therapy pipeline progress (5101, 5201)
Adaptimmune collaboration / uza-cel
BCMA / 5301 Parkinsonism safety event
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-28
Lakefront Biotherapeutics NV (LKFT) Q1 2024 Earnings Call Transcript
Positive tone
Pipeline and R&D strategy
Regulatory milestones (IND submissions)
Cell therapy programs (5101, 5201, 5301)
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q2 2021 Earnings Call Transcript
Revenue
139.77M EUR
▲ 40.4% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Lakefront Biotherapeutics NV (LKFT) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q2 2020 Earnings Call Transcript
Revenue
99.59M EUR
▲ 69.5% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Date not confirmed
Lakefront Biotherapeutics NV (LKFT) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–29 of 29 webcasts
Key facts
CIK
1421876
CUSIP
36315X101
13F (30d)
14 filings
14 filers
Visit website
Investor relations